Wynn Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.91M Buy
15,388
+52
+0.3% +$12.1K 1.74% 16
2026
Q1
$3.75M Sell
15,336
-208
-1% -$48.4K 1.93% 15
2025
Q4
$3.22M Sell
15,544
-386
-2% -$76.3K 1.56% 17
2025
Q3
$2.95M Buy
15,930
+57
+0.4% +$9.77K 1.43% 18
2025
Q2
$2.42M Sell
15,873
-34
-0.2% -$5.23K 1.29% 21
2025
Q1
$2.64M Buy
15,907
+3,260
+26% +$510K 1.57% 18
2024
Q4
$1.83M Buy
12,647
+178
+1% +$27.6K 1.15% 24
2024
Q3
$2.02M Buy
12,469
+217
+2% +$34.6K 1.32% 19
2024
Q2
$1.79M Buy
12,252
+192
+2% +$28.6K 1.32% 23
2024
Q1
$1.91M Sell
12,060
-125
-1% -$19.9K 1.47% 19
2023
Q4
$1.91M Buy
+12,185
New +$1.87M 1.56% 16

Other funds holding JNJ

Wynn Capital's JNJ Position: Q2 2026 in Review

Wynn Capital increased its Johnson & Johnson (JNJ) stake by 0.34% in Q2 2026, buying an estimated $12.1K and bringing the position to 15,388 shares worth $3.91M. The position accounts for 1.74% of the portfolio, ranked #16.

Wynn Capital first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 2,322 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Wynn Capital held 15,388 shares of Johnson & Johnson worth $3.91M as of Q2 2026.
  • Wynn Capital bought 52 Johnson & Johnson shares in Q2 2026, an estimated $12.1K.
  • Johnson & Johnson made up 1.74% of Wynn Capital's portfolio in Q2 2026, its #16 holding.
  • Wynn Capital first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 2,322 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Wynn Capital's 13F filing for Q2 2026, filed 8 Jul 2026.